BVF II GP LLC, 10% Owner at Cullinan Oncology, Inc. (CGEM), bought 552,000 shares at $10.75 ($5.9M) on 2022-04-01, disclosed to the SEC on 2022-04-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.75 | 9,402 | $101K | 1.7% |
| 2 | $10.75 | 9,402 | $101K | 1.7% |
| 3 | $10.75 | 266,598 | $2.9M | 48.3% |
| 4 | $10.75 | 266,598 | $2.9M | 48.3% |
| Total | $10.75 avg | 552,000 | $5.9M | 100% |
| Filing → |
| RPTX | BUY | 2022-06-06 | $43.7M | — | Filing → |
| CTIC | BUY | 2021-04-05 | $7.6M | — | Filing → |
| MRUS | BUY | 2021-03-24 | $1.8M | — | Filing → |